高敏C反应蛋白升高与腹主动脉瘤风险:挪威HUNT研究的前瞻性人群研究
该前瞻性人群队列纳入挪威HUNT研究中46322名参与者(女性53.7%),中位随访12.6年(范围0-26年)期间407人诊断为腹主动脉瘤(女性22.4%)。调整吸烟、冠心病、高血压、糖尿病、体重指数和总胆固醇后,hs-CRP每升高1 mg/L的腹主动脉瘤风险HR为1.02(95%CI 1.01-1.03),hs-CRP≥2 mg/L者风险接近翻倍(调整HR 1.84,95%CI 1.51-2.25)。结论认为hs-CRP升高者发生腹主动脉瘤风险显著增加。
要点
- hs-CRP每升高1 mg/L,腹主动脉瘤风险HR为1.02(95%CI 1.01-1.03)。
- hs-CRP≥2 mg/L者腹主动脉瘤风险接近翻倍(调整HR 1.84,95%CI 1.51-2.25)。
- 最高四分位(hs-CRP>2.7 mg/L)较低四分位(≤0.6 mg/L)风险近4倍(HR 3.87,95%CI 2.54-5.92)。
核心结论
- hs-CRP升高者发生腹主动脉瘤的风险显著增加。
研究设计与样本
- 前瞻性人群队列研究,纳入挪威Trøndelag健康研究(HUNT)46322名参与者,女性占53.7%。
- 中位随访12.6年(范围0-26年),期间407人诊断为腹主动脉瘤(女性占22.4%)。
- 采用Cox比例风险回归分析hs-CRP与腹主动脉瘤风险的关联,hs-CRP按连续变量或分类变量处理(以2 mg/L、1 mg/L、中位数1.2 mg/L二分,或按四分位数分组)。
主要发现
- 调整吸烟、冠心病、高血压、糖尿病、体重指数和总胆固醇后,hs-CRP每升高1 mg/L的腹主动脉瘤风险HR为1.02(95%CI 1.01-1.03)。
- hs-CRP≥2 mg/L者较hs-CRP<2 mg/L者腹主动脉瘤风险接近翻倍(调整HR 1.84,95%CI 1.51-2.25)。
- 以临床切点1 mg/L二分时调整HR为2.13(95%CI 1.64-2.76),以中位数1.2 mg/L二分时调整HR为2.12(95%CI 1.62-2.76)。
- 按hs-CRP四分位序次,调整HR逐渐升高,最高四分位(hs-CRP>2.7 mg/L)较低四分位(hs-CRP≤0.6 mg/L)风险近4倍(HR 3.87,95%CI 2.54-5.92)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Inflammation seems to be crucial in the pathogenesis of abdominal aortic aneurysm (AAA). Previous research links inflammatory biomarkers, such as high sensitivity C reactive protein (hs-CRP), to AAA. Few studies, however, have used a prospective design. The aim of this study was to examine whether individuals with elevated hs-CRP have increased risk of AAA, using a prospective and population based design. METHODS: This prospective, population based, cohort study included 46 322 participants in the Trøndelag Health Study (HUNT) in Norway (53.7% female). During a median follow up of 12.6 years (range 0 - 26 years), 407 individuals were diagnosed with AAA (22.4% female). Cox proportional hazards regression was applied to examine associations between hs-CRP and risk of AAA. hs-CRP was treated either as a continuous or a categorical variable (dichotomised at 2 mg/L, 1 mg/L, or median [1.2 mg/L], or as quartiles). RESULTS: The hazard ratio (HR) of developing AAA per 1 mg/L increase in hs-CRP (continuous hs-CRP) was 1.02 (95% confidence interval [CI] 1.01 - 1.03) in the analysis adjusted for smoking, coronary heart disease, hypertension, diabetes, body mass index, and total cholesterol. Individuals with hs-CRP ≥ 2 mg/L had almost twice the risk of AAA compared with individuals with hs-CRP < 2 mg/L (adjusted HR 1.84, 95% CI 1.51 - 2.25). Dichotomising hs-CRP at a clinical cutoff point of 1 mg/L (adjusted HR 2.13, 95% CI 1.64 -2.76) or at the median of 1.2 mg/L (adjusted HR 2.12, 95% CI 1.62 - 2.76) slightly strengthened the HR. The adjusted HR gradually increased through the ordered hs-CRP quartiles, and was almost four times higher (HR 3.87, 95% CI 2.54 - 5.92) in the highest hs-CRP quartile (hs-CRP > 2.7 mg/L) compared with the lowest quartile (hs-CRP ≤ 0.6 mg/L). CONCLUSION: Individuals with elevated hs-CRP had significantly increased risk of developing AAA.
引用
- Håland AB, Mattsson E, Videm V, et al. Elevated High Sensitivity C Reactive Protein and Risk of Abdominal Aortic Aneurysm: A Prospective Population Based Study in The Norwegian HUNT Study. Eur J Vasc Endovasc Surg. 2025. PMID: 39798633. doi:10.1016/j.ejvs.2024.12.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。